Literature DB >> 7771479

Clinical factors associated with urinary albumin excretion in type II diabetes.

S Savage1, N J Nagel, R O Estacio, N Lukken, R W Schrier.   

Abstract

Clinical factors associated with urinary albumin excretion (UAE) in type II diabetes are less well known than in type I diabetes. To examine the factors associated with UAE in type II diabetes, 933 Appropriate Blood Pressure Control in Diabetes Trial patients were classified according to UAE status: normoalbuminuria (< 20 micrograms/min), microalbuminuria (20 to 200 micrograms/min), and macroalbuminuria (> 200 micrograms/min). The class of UAE was then correlated with various clinical factors. Using univariate analyses, Hispanic ethnicity, African-American race, male gender, poor glycemic control, insulin use, long duration of diabetes, dyslipidemia, diastolic and systolic hypertension, smoking, and obesity were significantly correlated with microalbuminuria and macroalbuminuria. Using multivariate logistic regression analyses controlling for diabetes duration, glycosylated hemoglobin, gender, and race, the most significant predictors of microalbuminuria and macroalbuminuria were systolic hypertension, body mass index, high-density lipoprotein cholesterol, insulin use, and smoking pack-years. Of these factors, several are potentially reversible with aggressive intervention.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771479     DOI: 10.1016/0272-6386(95)90565-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  18 in total

Review 1.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

2.  Lifestyle factors and indices of kidney function in the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Paul F Jacques; Caroline S Fox; Audrey Y Chu
Journal:  Am J Nephrol       Date:  2015-05-20       Impact factor: 3.754

3.  Cigarette smoking, proteinuria, and renal function in middle-aged Japanese men from an occupational population.

Authors:  Yuka Noborisaka; Masao Ishizaki; Minori Nakata; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2011-08-24       Impact factor: 3.674

4.  Comparison of diabetic nephropathy between male and female eNOS-/- db/db mice.

Authors:  Yuhong Ma; Weizu Li; Parisa Yazdizadeh Shotorbani; Brooke Hopkins Dubansky; Linjing Huang; Sarika Chaudhari; Peiwen Wu; Lei A Wang; Myoung-Gwi Ryou; Zhengyang Zhou; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

Review 5.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

Review 6.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 7.  Sex, diabetes and the kidney.

Authors:  Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

8.  Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.

Authors:  Hyeong Cheon Park; So Rae Choi; Beom Seok Kim; Tae Hee Lee; Byung Seung Kang; Kyu Hyun Choi; Ho Yung Lee; Dae Suk Han; Sung-Kyu Ha
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

9.  Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects.

Authors:  Jaime J Jayapalan; Sekaran Muniandy; Siew P Chan
Journal:  Indian J Hum Genet       Date:  2010-05

Review 10.  Nicotine signaling and progression of chronic kidney disease in smokers.

Authors:  Gaurav Jain; Edgar A Jaimes
Journal:  Biochem Pharmacol       Date:  2013-07-26       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.